| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Xiaodong Zheng CEO | XSHE Exchange | CNE100000ZP0 ISIN |
| CN Country | 5,417 Employees | 1 Jun 2026 Last Dividend | 9 Jul 2014 Last Split | 1 Feb 2011 IPO Date |
Tofflon Science and Technology Group Co., Ltd., initially established as Shanghai Tofflon Science and Technology Co., Ltd., has carved a niche as a prestigious pharmaceutical equipment supplier serving the pharma and biotech sectors globally since its inception in 1993. Headquartered in Shanghai, China, the company specializes in a vast range of products and solutions aimed at revolutionizing pharmaceutical production processes. The company's dedication to innovation, quality, and service has positioned it as a leader in providing cutting-edge equipment and systems for various pharmaceutical applications.
Below are the detailed offerings by Tofflon Science and Technology Group Co., Ltd.:
This includes a comprehensive suite of solutions like auto solution preparation systems, aseptic filling lines for ampoules, vials, syringes, powders, freeze dryers, and auto loading systems. These technologies ensure sterile processing, enhancing the safety and efficacy of injectable pharmaceutical products.
Designed to safeguard the sterility and integrity of pharmaceutical products, these systems play a pivotal role in preventing contamination and ensuring product safety throughout the manufacturing process.
Tofflon offers advanced plastic packaging solutions tailored to meet the specific needs of the pharmaceutical and biotech industries, ensuring durability, safety, and compliance with regulatory standards.
The company provides essential ingredients required for drug formulation, emphasizing purity, efficiency, and consistency to meet the stringent quality demands of the pharmaceutical industry.
These systems are crucial for ensuring the quality and integrity of pharmaceutical products by identifying defects, ensuring proper sealing, and verifying product combinations for compliance with industry standards.
Encompassing a range of services from medium preparation, cell/microbial cultivation, harvesting, DF/UF (diafiltration/ultrafiltration), purification, buffer preparation to finished filling systems, Tofflon's offerings cater to the upstream and downstream processes in biopharmaceutical production.
These services focus on the freeze-drying technique, a critical process in the pharmaceutical industry for extending the shelf life of products, especially injectables, by removing water from the product under low temperature and vacuum.